Skip to main content
SpringerLink
Log in

Tramadol Extended-Release Tablets

A Viewpoint by Bill H. McCarberg

  • Adis Drug Profiles
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. ULTRAM® (tramadol hydrochloride tablets). US prescribing information May 2004. Ortho-McNeil Pharmaceutical, Inc., Raritan (NJ) [online]. Available from URL: http://www.ortho-mcneil.com [Accessed 2006 Oct 2]

  2. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43(9): 1905–15

    Article  Google Scholar 

  3. Hudson L, Richard H, Pilote L. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib or non-steroidal anti-inflammatory drugs: population based study. BMJ 2005 Jun 11; 330(7504): 1370

    Article  PubMed  CAS  Google Scholar 

  4. Caldwell B, Aldington S, Weatherall M, et al. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006; 99(3): 132–40

    Article  PubMed  CAS  Google Scholar 

  5. National Pharmaceutical Council, Inc., Joint Commission on Accreditation of Healthcare Organizations. Pain: current understanding of assessment, management, and treatments. Reston (VA): National Pharmaceutical Council, Inc., 2001 [online]. Available from URL: http://www.npcnow.org/resources/PDFs/painmonograph.pdf [Accessed 2006 Sep 26]

  6. Weinstein SM, Laux LF, Thornby JI, et al. Physicians’ attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J 2000; 93(5): 479–87

    PubMed  CAS  Google Scholar 

  7. ULTRAM® ER (tramadol HCl) extended-release tablets. US prescribing information January 2006. Ortho-McNeil, Inc., Raritan (NJ) [online]. Available from URL: http://www.ortho-mcneil.com [Accessed 2006 Oct 2]

  8. Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004; 28(1): 59–71

    Article  PubMed  CAS  Google Scholar 

  9. Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. 023 Study Group. Curr Med Res Opin 2006; 22(7): 1391–401

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kaiser Permanente, Escondido, California, USA

    Bill H. McCarberg

Authors
  1. Bill H. McCarberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCarberg, B.H. Tramadol Extended-Release Tablets. Drugs 66, 2028–2030 (2006). https://doi.org/10.2165/00003495-200666150-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666150-00017

Search

Navigation